LaBarre Michael J. (CIK 0001507174)

Latest company ownership

HALO - HALOZYME THERAPEUTICS, INC.
Role: SVP, CHIEF TECHNICAL OFFICER
Shares held
173,756
Last filed at
Feb 27, 2025
Confidence Score
49.4
2025Q4
Confidence Score History
2020Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 25, 2025 Feb 27, 2025 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 20.0 -21,697 -11.10% ✓ $1.3M
Feb 23, 2025 Feb 24, 2025 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 42.5 -2,410 -1.22% ✗ $139.2K
Feb 15, 2025 Feb 18, 2025 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 40.0 -15,292 -2.00% ✗ $891.4K
Oct 15, 2024 Oct 16, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 32.5 -20,000 -3.69% ✓ $1.1M
Sep 17, 2024 Sep 18, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 32.5 -20,000 -3.68% ✓ $1.2M
Aug 20, 2024 Aug 21, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 32.5 -20,000 -3.81% ✓ $1.2M
Jul 23, 2024 Jul 24, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 32.5 -20,000 -3.77% ✓ $1.1M
Jun 18, 2024 Jun 20, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -10,000 -5.61% ✓ $494.3K
May 21, 2024 May 22, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -20,000 -5.61% ✓ $905.5K
Apr 16, 2024 Apr 17, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -20,000 -5.61% ✓ $768.4K
Mar 12, 2024 Mar 13, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -20,000 -6.00% ✓ $839.1K
Feb 27, 2024 Feb 28, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 35.0 -20,000 -4.06% ✓ $794.9K
Feb 16, 2024 Feb 20, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 42.5 -5,257 -1.54% ✗ $189.8K
Feb 15, 2024 Feb 16, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 82.5 +3,439 2.14% ✗ $181K
Feb 10, 2024 Feb 13, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 42.5 -2,901 -1.81% ✗ $103K
Jan 16, 2024 Jan 18, 2024 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -20,000 -6.18% ✓ $720K
Dec 12, 2023 Dec 13, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 35.0 -20,000 -4.20% ✓ $800.3K
Nov 14, 2023 Nov 16, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 35.0 -20,000 -4.20% ✓ $788.7K
Oct 17, 2023 Oct 17, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -10,000 -6.18% ✓ $365.2K
Sep 19, 2023 Sep 19, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -10,000 -6.18% ✓ $391K
Aug 22, 2023 Aug 23, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 35.0 -10,000 -3.19% ✓ $424.1K
Jul 18, 2023 Jul 19, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -10,000 -6.58% ✓ $404.3K
Jun 21, 2023 Jun 22, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -10,000 -6.58% ✓ $360K
Apr 18, 2023 Apr 19, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -10,000 -6.58% ✓ $360K
Feb 27, 2023 Apr 19, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 41.3 -2,984 -2.06% ✓ $147.9K
Feb 27, 2023 Feb 28, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -10,000 -6.71% ✓ $495.5K
Feb 16, 2023 Feb 21, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 42.5 -2,878 -1.90% ✗ $141.8K
Feb 15, 2023 Feb 17, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 35.0 -11,170 -3.72% ✓ $541.5K
Feb 10, 2023 Feb 14, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 40.0 -5,676 -1.85% ✗ $277.7K
Jan 17, 2023 Jan 18, 2023 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -10,000 -6.53% ✓ $504.6K
Dec 13, 2022 Dec 13, 2022 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -10,000 -6.13% ✓ $586.7K
Nov 15, 2022 Nov 16, 2022 HALOZYME THERAPEUTICS, INC. SVP, CHIEF TECHNICAL OFFICER Sell 30.0 -10,000 -5.78% ✓ $541.3K
Feb 15, 2022 Feb 17, 2022 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 48.8 -1,170 -0.67% ✗ $40.3K
Feb 10, 2022 Feb 14, 2022 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 40.0 -7,712 -1.52% ✗ $264.8K
Oct 1, 2021 Oct 1, 2021 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 15.0 -29,450 -16.52% ✓ $1.2M
Jul 1, 2021 Jul 6, 2021 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 10.0 -40,315 -23.11% ✓ $1.8M
Apr 1, 2021 Apr 1, 2021 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 15.0 -28,689 -18.94% ✓ $1.2M
Mar 1, 2021 Mar 1, 2021 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 22.5 -18,324 -12.98% ✓ $839.4K
Feb 22, 2021 Feb 22, 2021 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 42.5 -4,364 -3.00% ✗ $212.5K
Feb 14, 2021 Feb 16, 2021 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 42.5 -2,272 -1.64% ✗ $113.2K
Feb 10, 2021 Feb 12, 2021 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 40.0 -5,631 -2.11% ✗ $282.9K
Dec 21, 2020 Dec 21, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 26.3 -12,000 -8.90% ✓ $510.9K
Nov 20, 2020 Nov 20, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 26.3 -12,000 -8.17% ✓ $465.2K
Oct 20, 2020 Oct 20, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 26.3 -12,000 -7.56% ✓ $365.1K
Sep 21, 2020 Sep 21, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 30.0 -12,000 -7.03% ✓ $322.9K
Aug 20, 2020 Aug 20, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 30.0 -12,000 -6.56% ✓ $339.6K
Jul 20, 2020 Jul 20, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 30.0 -12,000 -6.16% ✓ $348.1K
May 20, 2020 May 21, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 22.5 -21,387 -10.82% ✓ $509.1K
Feb 22, 2020 Feb 24, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 42.5 -3,044 -1.70% ✗ $66.5K
Feb 14, 2020 Feb 18, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 46.3 -1,995 -1.16% ✗ $42.1K
Feb 12, 2020 Feb 13, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 42.5 -2,725 -1.61% ✗ $54.5K
Feb 3, 2020 Feb 4, 2020 HALOZYME THERAPEUTICS, INC. SVP, Chief Technical Officer Sell 42.5 -4,289 -2.59% ✗ $82.4K